Annual EBITDA
N/A
31 December 2023
Summary:
AEON Biopharma annual earnings before interest, taxes, depreciation & amortization is not available.AEON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.69 M
+$174.08 M+97.92%
30 September 2024
Summary:
AEON Biopharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.69 million, with the most recent change of +$174.08 million (+97.92%) on 30 September 2024. AEON quarterly EBITDA is now -103.80% below its all-time high of $97.23 million, reached on 31 March 2024.AEON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$84.24 M
-$3.69 M-4.59%
30 September 2024
Summary:
AEON Biopharma TTM earnings before interest, taxes, depreciation & amortization is currently -$84.24 million, with the most recent change of -$3.69 million (-4.59%) on 30 September 2024. AEON TTM EBITDA is now -201.15% below its all-time high of $83.28 million, reached on 31 March 2024.AEON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AEON EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AEON EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -103.8% | +97.9% | -201.2% | at low | ||
| 5 y | 5 years | -103.8% | +97.9% | -201.2% | at low | ||
| alltime | all time | -103.8% | +97.9% | -201.2% | at low |
AEON Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.69 M(-97.9%) | -$84.24 M(+4.6%) |
| June 2024 | - | -$177.78 M(-282.8%) | -$80.55 M(-196.7%) |
| Mar 2024 | - | $97.23 M(-797.1%) | $83.28 M(-260.5%) |
| June 2023 | - | -$13.95 M(+7.1%) | -$51.88 M(+36.8%) |
| Mar 2023 | - | -$13.02 M(-13.2%) | -$37.94 M(+52.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$48.36 M(+31.1%) | -$15.00 M(+51.3%) | -$24.91 M(+151.3%) |
| Sept 2022 | - | -$9.91 M | -$9.91 M |
| Dec 2021 | -$36.88 M(+12.1%) | - | - |
| Dec 2020 | -$32.90 M(-121.3%) | - | - |
| Dec 2019 | $154.40 M | - | - |
FAQ
- What is the all time high annual EBITDA for AEON Biopharma?
- What is AEON Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for AEON Biopharma?
- What is AEON Biopharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for AEON Biopharma?
What is the all time high annual EBITDA for AEON Biopharma?
AEON Biopharma all-time high annual earnings before interest, taxes, depreciation & amortization is $154.40 M
What is AEON Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of AEON is -$3.69 M
What is the all time high quarterly EBITDA for AEON Biopharma?
AEON Biopharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $97.23 M
What is AEON Biopharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of AEON is -$84.24 M
What is the all time high TTM EBITDA for AEON Biopharma?
AEON Biopharma all-time high TTM earnings before interest, taxes, depreciation & amortization is $83.28 M